clinical trial · NCT07925359
The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Used With the FARAWAVE NAV™ ULTRA Pulsed Field Ablation Catheter in the Treatment of Atrial Fibrillation
Atrial Fibrillation (AF)Paroxysmal AFPersistent Atrial Fibrillation (PersAF)FARAPULSEAblation Treatment with FARAPULSE™ Pulsed Field Ablation (PFA) System and OPAL HDx™ Mapping System
brief summary
The objective of this study is to obtain experience with new and modified components of the FARAPULSE™ Pulsed Field Ablation (PFA) System when used with the OPAL HDx™ Mapping System for the treatment of Atrial Fibrillation (AF).
started
Jan 20, 2027
primary completion
Oct 1, 2027
completion
Oct 1, 2027
last updated
Nov 9, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol